Vitamin E to Treat Uveitis-Associated Macular Edema
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether vitamin E can help treat swelling of the macular area of the
retina (the back part of the eye) associated with uveitis (inflammatory eye disease). The
macula is responsible for sharp vision; swelling in this area is one cause of vision loss in
uveitis patients. Macular swelling is also associated with eye problems related to diabetes.
In these patients, the swelling is thought to be caused by a substance called vascular
endothelial growth factor, or VEGF. High doses of vitamin E have been used to treat these eye
problems in diabetics. This study is a first step to find out if vitamin E will help reduce
the retinal swelling in uveitis, which may also be caused by VEGF.
Patients 9 years of age and older with macular edema associated with uveitis may be eligible
for this study. Candidates will be screened with the following tests and procedures:
- Medical history and physical examination. This includes measurement of vital signs
(blood pressure, pulse, temperature and breathing rate) and examination of the head and
neck, heart, lungs, abdomen, arms and legs.
- Eye examination. This includes measurement of visual acuity using a vision chart,
measurement of eye pressure and examination of the pupils and eye movements. The pupils
will be dilated with drops to permit examination of the back of the eye.
- Fluorescein angiography. This test uses a yellow dye (fluorescein) to take photos of the
retina. The fluorescein is injected into an arm vein and travels to the blood vessels in
the eye. The camera flashes a blue light into the eye and takes pictures of the retina.
The pictures show if the dye has leaked from the blood vessels into the retina.
- Stereoscopic color fundus photography. These are photographs of the back of the eye,
taken after the pupils have been dilated with drops.
- Optical coherence tomography. This test measures the macular swelling. It is used to
determine if the swelling is getting worse, better or staying the same.
- Blood tests. About a tablespoon of blood is drawn to measure inflammation and cell
counts and side effects of treatment.
- Pregnancy test. All women of child-bearing potential are tested for pregnancy.
Participants will be randomly assigned to daily treatment with oral high-dose vitamin E (1600
units) or placebo (a pill with no active ingredient) for 4 months. They will be examined at 2
months and 4 months with the same tests performed for screening and will return for a final
clinic visit 1 month after treatment has ended.
Phase:
Phase 1
Details
Lead Sponsor:
National Eye Institute (NEI)
Treatments:
alpha-Tocopherol Tocopherols Tocotrienols Vitamin E Vitamins